Terms: = Uterine cancer AND MAML2, MAM3, 84441, ENSG00000184384, MAM-3, MLL-MAML2, Q8IZL2, KIAA1819, DKFZp686N0150, MAM2
4 results:
1. A Complex Interplay between Notch Effectors and β-Catenin Signaling in Morular Differentiation of Endometrial Carcinoma Cells.
Yokoi A; Murayama A; Hashimura M; Oguri Y; Harada Y; Fukagawa N; Hayashi M; Ono M; Ohhigata K; Saegusa M
Am J Pathol; 2024 Mar; 194(3):459-470. PubMed ID: 38096983
[TBL] [Abstract] [Full Text] [Related]
2. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-maml2 gene fusion.
Lennerz JK; Perry A; Mills JC; Huettner PC; Pfeifer JD
Am J Surg Pathol; 2009 Jun; 33(6):835-43. PubMed ID: 19092631
[TBL] [Abstract] [Full Text] [Related]
3. Human milk-fat globule membrane antigens (mam-3 group) in normal cycling endometrium and endometrial carcinomas--an immunohistochemical study. A preliminary report.
Ravn V; Jensen H; Hilgers J
APMIS; 1989 May; 97(5):452-8. PubMed ID: 2659045
[TBL] [Abstract] [Full Text] [Related]
4. Expression of mam-3 and MAM-6 antigens in endometrial and endocervical adenocarcinomas.
Tsubura A; Morii S; Hilkens J; Hilgers J
Virchows Arch A Pathol Anat Histopathol; 1985; 407(1):59-67. PubMed ID: 3925626
[TBL] [Abstract] [Full Text] [Related]